Literature DB >> 29157081

Regulation of BECN1-mediated autophagy by HSPB6: Insights from a human HSPB6S10F mutant.

Guan-Sheng Liu1, Hongyan Zhu1, Wen-Feng Cai2, Xiaohong Wang1, Min Jiang3, Kobina Essandoh1, Elizabeth Vafiadaki4, Kobra Haghighi1, Chi Keung Lam1, George Gardner1, George Adly1, Persoulla Nicolaou1, Despina Sanoudou4, Qiangrong Liang5, Jack Rubinstein3, Guo-Chang Fan1, Evangelia G Kranias1,4.   

Abstract

HSPB6/Hsp20 (heat shock protein family B [small] member 6) has emerged as a novel cardioprotector against stress-induced injury. We identified a human mutant of HSPB6 (HSPB6S10F) exclusively present in dilated cardiomyopathy (DCM) patients. Cardiac expression of this mutant in mouse hearts resulted in remodeling and dysfunction, which progressed to heart failure and early death. These detrimental effects were associated with reduced interaction of mutant HSPB6S10F with BECN1/Beclin 1, leading to BECN1 ubiquitination and its proteosomal degradation. As a result, autophagy flux was substantially inhibited and apoptosis was increased in HSPB6S10F-mutant hearts. In contrast, overexpression of wild-type HSPB6 (HSPB6 WT) not only increased BECN1 levels, but also competitively suppressed binding of BECN1 to BCL2, resulting in stimulated autophagy. Indeed, preinhibition of autophagy attenuated the cardioprotective effects of HSPB6 WT. Taken together, these findings reveal a new regulatory mechanism of HSPB6 in cell survival through its interaction with BECN1. Furthermore, Ser10 appears to be crucial for the protective effects of HSPB6 and transversion of this amino acid to Phe contributes to cardiomyopathy.

Entities:  

Keywords:  BECN1; HSPB6; autophagy; heart failure; human mutation

Mesh:

Substances:

Year:  2018        PMID: 29157081      PMCID: PMC5846551          DOI: 10.1080/15548627.2017.1392420

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  50 in total

1.  Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis.

Authors:  Yushan Zhu; Lixia Zhao; Lei Liu; Ping Gao; Weili Tian; Xiaohui Wang; Haijing Jin; Haidong Xu; Quan Chen
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

2.  Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling.

Authors:  Jiang Qian; Elizabeth Vafiadaki; Stela M Florea; Vivek P Singh; Weizhong Song; Chi Kung Lam; Yigang Wang; Qunying Yuan; Tracy J Pritchard; Wenfeng Cai; Kobra Haghighi; Patricia Rodriguez; Hong-Sheng Wang; Despina Sanoudou; Guo-Chang Fan; Evangelia G Kranias
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

3.  The mammalian small heat-shock protein Hsp20 forms dimers and is a poor chaperone.

Authors:  F A van de Klundert; R H Smulders; M L Gijsen; R A Lindner; R Jaenicke; J A Carver; W W de Jong
Journal:  Eur J Biochem       Date:  1998-12-15

4.  Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways.

Authors:  Chen Chen; Yan Meng; Lei Wang; Hong-Xia Wang; Cui Tian; Guo-Dong Pang; Hui-Hua Li; Jie Du
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 5.  Methods in cardiomyocyte isolation, culture, and gene transfer.

Authors:  William E Louch; Katherine A Sheehan; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2011-06-24       Impact factor: 5.000

6.  A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.

Authors:  Guan-Sheng Liu; Ana Morales; Elizabeth Vafiadaki; Chi Keung Lam; Wen-Feng Cai; Kobra Haghighi; George Adly; Ray E Hershberger; Evangelia G Kranias
Journal:  Cardiovasc Res       Date:  2015-04-07       Impact factor: 10.787

7.  Inhibition of macroautophagy triggers apoptosis.

Authors:  Patricia Boya; Rosa-Ana González-Polo; Noelia Casares; Jean-Luc Perfettini; Philippe Dessen; Nathanael Larochette; Didier Métivier; Daniel Meley; Sylvie Souquere; Tamotsu Yoshimori; Gérard Pierron; Patrice Codogno; Guido Kroemer
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 8.  Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Authors:  D Chen; M Frezza; S Schmitt; J Kanwar; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

9.  MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.

Authors:  Jinghai Wu; Xiao-Ping Ren; Xiaohong Wang; Maureen A Sartor; Keith Jones; Jiang Qian; Persoulla Nicolaou; Tracy J Pritchard; Guo-Chang Fan
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

Review 10.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

View more
  14 in total

Review 1.  The BAG3-dependent and -independent roles of cardiac small heat shock proteins.

Authors:  Xi Fang; Julius Bogomolovas; Christa Trexler; Ju Chen
Journal:  JCI Insight       Date:  2019-02-21

2.  WIPI1 is a conserved mediator of right ventricular failure.

Authors:  Christos Tzimas; Christoph D Rau; Petra E Buergisser; Gaston Jean-Louis; Katherine Lee; Jeffrey Chukwuneke; Wen Dun; Yibin Wang; Emily J Tsai
Journal:  JCI Insight       Date:  2019-04-25

3.  Tissue-specific small heat shock protein 20 activation is not associated with traditional autophagy markers in Ossabaw swine with cardiometabolic heart failure.

Authors:  Kleiton Augusto Santos Silva; Emily V Leary; T Dylan Olver; Timothy L Domeier; Jaume Padilla; R Scott Rector; Craig A Emter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-18       Impact factor: 4.733

Review 4.  Animal Models of Cardiovascular Complications of Pregnancy.

Authors:  Zolt Arany; Denise Hilfiker-Kleiner; S Ananth Karumanchi
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

5.  Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.

Authors:  Huamei Tang; Lijuan Kan; Tong Ou; Dayang Chen; Xiaowen Dou; Wei Wu; Xiang Ji; Mengmeng Wang; Zengyan Zong; Hongmei Mo; Xiuming Zhang; Dan Xiong
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

6.  Tsg101 positively regulates P62-Keap1-Nrf2 pathway to protect hearts against oxidative damage.

Authors:  Shan Deng; Kobina Essandoh; Xiaohong Wang; Yutian Li; Wei Huang; Jing Chen; Jiangtong Peng; Ding-Sheng Jiang; Xingjiang Mu; Chenran Wang; Tianqing Peng; Jun-Lin Guan; Yigang Wang; Anil Jegga; Kai Huang; Guo-Chang Fan
Journal:  Redox Biol       Date:  2020-02-06       Impact factor: 11.799

Review 7.  Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease.

Authors:  Jack M Webster; April L Darling; Vladimir N Uversky; Laura J Blair
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

8.  A novel human S10F-Hsp20 mutation induces lethal peripartum cardiomyopathy.

Authors:  Guan-Sheng Liu; George Gardner; George Adly; Min Jiang; Wen-Feng Cai; Chi Keung Lam; Fawzi Alogaili; Nathan Robbins; Jack Rubinstein; Evangelia G Kranias
Journal:  J Cell Mol Med       Date:  2018-05-15       Impact factor: 5.295

9.  Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 bodies.

Authors:  Mansour Haidar; Bob Asselbergh; Elias Adriaenssens; Vicky De Winter; Jean-Pierre Timmermans; Michaela Auer-Grumbach; Manisha Juneja; Vincent Timmerman
Journal:  Autophagy       Date:  2019-01-31       Impact factor: 16.016

10.  Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy.

Authors:  Evan Onusko; Michael R McDermott; Nathan Robbins; Guansheng Liu; Evangelia G Kranias; Jack Rubinstein; Sheryl E Koch
Journal:  PLoS One       Date:  2020-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.